Home / Products / Cancer (Tumor) Cell Lines / MKN45
MKN45
Datasheet Protocol

MKN45

Cat. No. ARC0524
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Stomach

Growth Properties:

Adherent and suspension

In stock
$1,300.00 / Vial
Ask a Question

Short Description 🔒

MKN45 is a cancer cell line of stomach adenocarcinoma, isolated from metastatic; liver.
 
Synonym: MKN-45

Recommended Products

NTPCR Knockout jurkat Polyclonal Cells NTPCR Knockout jurkat Polyclonal Cells Cat. No. ARG13322 GGACT Knockout A549 Polyclonal Cells GGACT Knockout A549 Polyclonal Cells Cat. No. ARG10598 ACOT7 Knockout 786-O Polyclonal Cells ACOT7 Knockout 786-O Polyclonal Cells Cat. No. ARG24805 GTF2IRD1 Knockout SK-HEP-1 Polyclonal Cells GTF2IRD1 Knockout SK-HEP-1 Polyclonal Cells Cat. No. ARG32524 CBX5 Knockout 769-P Polyclonal Cells CBX5 Knockout 769-P Polyclonal Cells Cat. No. ARG42768 MYO1C Knockout HEK293T Polyclonal Cells MYO1C Knockout HEK293T Polyclonal Cells Cat. No. ARG3364
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Stomach
Disease:
Adenocarcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent and suspension
Age:
62 years
Sex of Donor:
Female
Derived From Site:
Metastatic; Liver
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

CAPN13 Knockout HAP1 Polyclonal Cells

CAPN13 Knockout HAP1 Polyclonal Cells

Cat. No. ARG22250
 NT5C3A Knockout Hela Polyclonal Cells

NT5C3A Knockout Hela Polyclonal Cells

Cat. No. ARG8785
 ARPIN Knockout A2780 Polyclonal Cells

ARPIN Knockout A2780 Polyclonal Cells

Cat. No. ARG28802
 DNAJC21 Knockout A549 Polyclonal Cells

DNAJC21 Knockout A549 Polyclonal Cells

Cat. No. ARG39251
 MARCKS Knockout 786-O Polyclonal Cells

MARCKS Knockout 786-O Polyclonal Cells

Cat. No. ARG4651
 PARVG Knockout Raji Polyclonal Cells

PARVG Knockout Raji Polyclonal Cells

Cat. No. ARG1443